Gout Disease Treatment Market: Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

Report Code: ZMR-233 | Report Format : | Status : Upcoming |

Abstract

Gout is a disease that is caused by frequent attacks of acute inflammatory arthritis. The symptoms of this disease include red and swollen joint, itching skin, limited movement of the affected part, and others. Also, the uric acid crystallizes and the crystals deposit in joints, tendons and adjacent tissues which cause a gout attack. The human body produces uric acid when it is broken down into purines. Purines are substances that are already present naturally in the body in the form of food consumed by the humans. It is caused due to a combination of genetic factor and diet. Usually, the person consuming large amounts of meat and beer faces this disease.

The global gout disease treatment market is segmented on the basis of disease therapeutics and the conditional stage. The conditional stage segment is sub-segmented as acute gout and chronic gout. The therapeutic segment is further sub-segmented as urate-lowering therapies and inflammatory. The global market is segmented on the basis of the product as colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroids. NSAIDs are widely used for the treatment of gout disease, while corticosteroids and colchicines are the alternative treatment for the patients who are unable to tolerate the effects of NSAIDs.

The increase in the number of gout disease incidences and strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised study on gout therapeutics and introduction of niche drugs are other factors boosting the growth of the global gout disease treatment market. Progressive collaboration between major companies and quick product launches are some key factors impacting the growth of the market in a positive way. On the other hand, strict regulations and patent expiry of various drugs may act key restraining factors for the global gout disease treatment market.

North America and Europe dominate the global gout disease treatment market mainly owing to the enhanced pharmaceutical research in this area. North America is the leading player in the gout therapeutics market due to increased geriatric population with modernized routine disorders. In addition, the U.S holds the biggest market for gout disease treatment, followed by Canada in North America. Furthermore, Asia is anticipated to witness high growth in the near future owing to increasing awareness among people about the disease. Japan, China, and India are expected to grow rapidly in the gout disease treatment market in Asia.

Some of the major players dominating the global gout disease treatment market are Novartis AG, AstraZeneca PLC, Polaris Group, Teijin Pharma Limited, BioCryst Pharmaceuticals, Inc., Nippon Chemiphar Co., Ltd., and JW Pharmaceutical Corporation. Other key players influencing the global market are Addex Therapeutics, Takeda Pharmaceutical Company, LG Life Sciences Ltd., Pfizer, and Merck.

Gout Disease Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany 
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Bioprocess Technology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1560 | Report Format:

Global Bioprocess Technology Market: Overview The bioprocess technology plays a very vital role in the biotechnology industry. Desired products are procured in a bioprocess from the cells that are alive such as enzymes, bacteria, and chloroplast or their components. The bioprocess is leveraged i...Read More

Panic Disorders Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1505 | Report Format:

Global Panic Disorders Market: Overview When a patient suffers from frequent sudden panic attacks then that patient is suffering from the panic disorder which is a type of anxiety disorder. The patient has the following symptoms when panic attacks occur such as intense fear, sweating, shortness ...Read More

Healthcare Predictive Analytics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1454 | Report Format:

Global Healthcare Predictive Analytics Market: Overview A significant rise in the demand in the healthcare predictive market expected to be seen in the forecast period. This can be attributed to the increasing prices of medication facilities and increasing popularity of personalized medicines. R...Read More

Healthcare CRM market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1453 | Report Format:

Global Healthcare CRM market: Overview The basic concept of healthcare CRM market is to maintain a customer relationship management system in the healthcare sector. There are two methods in which the healthcare customers relations can be managed; one is to stay in touch with patients and the oth...Read More

Pharmacovigilance Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1418 | Report Format:

Global Pharmacovigilance Market: Overview Owing to the use of drugs or any of the pharmaceutical products if there are adverse effects arising then in order to prevent, detect, monitor, and collect it a scientific process is done which is known as pharmacovigilance. With the help of the services...Read More

Choose License Type:
Latest Published Reports

View All Published Reports